Status:
COMPLETED
NOWDx Test for the Detection of Antibodies to COVID-19
Lead Sponsor:
NOWDiagnostics, Inc.
Conditions:
COVID-19
SARS-CoV-2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is designed to compare the performance of the NOWDx COVID-19 Test to an emergency use authorized PCR test result. The intent is to show the rapid test device is comparable to a currently ma...
Detailed Description
This study is designed to compare the performance of the NOWDx COVID-19 Test to an emergency use authorized PCR test result. The intent is to show the rapid test device is comparable to a currently ma...
Eligibility Criteria
Inclusion
- Persons ≥18 years old;
- Persons who have tested positive or negative (within 6 days) for COVID-19 with an emergency use authorized molecular (PCR) test and can furnish said test report.
Exclusion
- Persons \<18 years old;
- Persons who have previously participated in a NOWDx study.
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT04690413
Start Date
September 1 2020
End Date
December 31 2020
Last Update
March 1 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Del Sol Research Management, LLC
Tucson, Arizona, United States, 85712
2
Comprehensive Clinical Research, LLC
West Palm Beach, Florida, United States, 33409
3
Clinical Research Solutions, LLC
Jackson, Tennessee, United States, 38305